Fig. 1

Study schema. *Proportion of patients receiving each type of T2DM therapy (AD or insulin) as first-line treatment. ^Features of drug-naive patients treated with the first and second most frequently used outpatient AD monotherapy. #Proportion of patients with T2DM undergoing one or more examinations for diabetic complications of interest. AD antidiabetes, HbA1c glycated hemoglobin, MDV Medical Data Vision, T2DM type 2 diabetes mellitus